Management provided a 2025 EPS guidance range of $9.60 to $10.40, with a midpoint of $10, reflecting approximately 10% growth. This includes $54 million in incremental synergies and a projected EBITDA ...
Raymond James resumed coverage of Regenxbio (RGNX) with an Outperform rating and $27 price target The firm expects the launch of Elevidys and ...
4h
WGMB Baton Rouge on MSNLexus LX 700h: Luxury Hybrid SUV Redefines ExcellenceLexus has made a name for itself by crafting vehicles that marry reliability with sophistication, and the all-new LX 700h builds on that legacy. With this flagship SUV, Lexus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results